SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-354663
Filing Date
2021-12-13
Accepted
2021-12-13 08:01:00
Documents
12
Period of Report
2021-12-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d224639d8k.htm   iXBRL 8-K 24240
  Complete submission text file 0001193125-21-354663.txt   146893

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20211213.xsd EX-101.SCH 2931
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20211213_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20211213_pre.xml EX-101.PRE 11431
5 EXTRACTED XBRL INSTANCE DOCUMENT d224639d8k_htm.xml XML 3360
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 211486995
SIC: 2834 Pharmaceutical Preparations